Renaissance Technologies - ADAGIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ADAGIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$83
+232.0%
48,785
+101.6%
0.00%
Q2 2023$250.0%24,200
+18.0%
0.00%
Q1 2023$25
+4.2%
20,500
+29.7%
0.00%
Q4 2022$2415,8000.00%
Other shareholders
ADAGIO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 9,248,250$15,722,02518.03%
Alphabet Inc. 5,680,785$9,657,3340.62%
683 Capital Management, LLC 4,000,000$6,800,0000.53%
Bain Capital Life Sciences Investors, LLC 1,937,207$3,293,2520.37%
Acuitas Investments, LLC 208,579$354,5840.21%
MAVERICK CAPITAL LTD 5,270,290$8,959,4930.20%
Orbimed Advisors 5,270,400$8,959,6800.19%
Slate Path Capital LP 3,735,000$6,349,5000.18%
Redmile Group, LLC 1,440,725$2,449,2330.12%
TANG CAPITAL MANAGEMENT LLC 366,536$623,1110.09%
View complete list of ADAGIO THERAPEUTICS INC shareholders